Pay to Marwadi

Company Profile

TTK HEALTHCARE LTD.

NSE : TTKHLTCAREBSE : 507747ISIN CODE : INE910C01018Industry : Pharmaceuticals & DrugsHouse : TTK
BSE1516.80-33.7 (-2.17 % )
PREV CLOSE (Rs.) 1550.50
OPEN PRICE (Rs.) 1540.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 591
TODAY'S LOW / HIGH (Rs.)1510.55 1564.45
52 WK LOW / HIGH (Rs.)1117.05 1725.85
NSE1515.65 -34.4 (-2.22 % )
PREV CLOSE(Rs.) 1550.05
OPEN PRICE (Rs.) 1500.55
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1515.65 (1 )
VOLUME 4393
TODAY'S LOW / HIGH(Rs.) 1500.55 1547.90
52 WK LOW / HIGH (Rs.)1101.2 1744

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 9.11077
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 6.16
ROCE (%) 10.13
Incorporation Year : 1958

Management Info :

T T Raghunathan - Chairman - Managing Director

Registered Office :

Address : No 6 , Cathedral Road, , ,
Chennai,
Tamil Nadu-600086

Phone : 044-28116106-08

Registrar's Details : Data Software Research Co Pvt Ltd
19 Pycroft Garden Road,Off Haddows Road,Nungambakkam,Chennai
Listing : BSE, NSE, MCX
NEWS More
22Dec12-22-2023$Ttk Healthcare informs about clarification Ttk Healthcare informs about
With acknowledge receipt of communication L/SURV/ONL/PV/NP/2023-2024/497 dated 22nd December, 2023, Ttk Healthcare has clarified that the company as of now, do not have any information / announcement (including impending announcement) about the Company which in its opinion may have a bearing on the price / volume behaviour in the scrip.

The above information is a part of company’s filings submitted to BSE.

With acknowledge receipt of communication L/SURV/ONL/PV/NP/2023..
21Nov11-21-2023$Ttk Healthcare informs about loss of share certificate Ttk Healthcare informs about
Ttk Healthcare has informed that it enclosed Certificate under Reg 39(3) of SEBI (LODR), 2015 - Loss of Share Certificate.

The above information is a part of company’s filings submitted to BSE.

Ttk Healthcare has informed that it enclosed Certificate under..
03Nov11-03-2023$Ttk Healthcare submits unaudited financial results Ttk Healthcare submits unaud
Ttk Healthcare has informed that it enclosed the Unaudited Financial Results along with the Limited Review Report from the Statutory Auditors of the Company, for the Second Quarter and Half-Year ended 30th September, 2023, duly reviewed by the Audit Committee at their meeting held yesterday on 2nd November, 2023 and approved by the Board of Directors of the Company at their Meeting held today.

The above information is a part of company’s filings submitted to BSE.


Ttk Healthcare has informed that it enclosed the Unaudited Fina..
17Aug08-17-2023$TTK Healthcare informs about details of loss of certificate TTK Healthcare informs about
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, TTK Healthcare has informed that Radhika Bahl jointly with Ajay Bahl who holds shares, has reported loss/ misplacement of Share Certificates. Radhika Bahl jointly with Ajay Bahl has already filed its Claim with the IEPF Authority, upon verification of the documents received from them, the Company shall file the E-verification Report accordingly.

The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015,..
26May05-26-2023$TTK Healthcare informs about secretarial compliance report TTK Healthcare informs about

In accordance with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, TTK Healthcare has forwarded the Secretarial Compliance Report dated 12th May, 2023, for the financial year ended 31st March, 2023, issued by Balu Sridhar, Partner, A K Jain & Associates, Practising Company Secretaries, Chennai 600084.

The above information is a part of company’s filings submitted to BSE.

In accordance with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit128.956397.15
Gross Profit 177 616.370000000001
Operating Profit 212.4796.820000000001
Net Sales 1838.477251.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Ajanta Pharma (BSE)
 2377.00 (6.44%)
M.Cap ( in Cr)
29930.39
Alkem Laboratories (BSE)
 4899.45 (2.36%)
M.Cap ( in Cr)
58580.27
Astrazeneca Pharma I (BSE)
 5424.45 (1.70%)
M.Cap ( in Cr)
13561.13
Dr. Reddy's Lab (BSE)
 6349.95 (0.98%)
M.Cap ( in Cr)
105928.76
Torrent Pharma (BSE)
 2732.60 (2.20%)
M.Cap ( in Cr)
92483.60
Shareholding Pattern More
PROMOTERS 74.56 %
NON-INSTITUTION 22.45 %
FII 1.85 %
FI/BANKS/INSURANCE 0.01 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
MF HOLDINGS More
Scheme NameHold(%)
Axis ELSS Tax Saver Fun...0.12
F & O Quotes